Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Genomic Testing and the Resulting Medical Decisions According to Target Identification

NCT03301493 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.

NCT NCT03301493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03301493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Genomic Testing and the Resulting Medical Decisions According to Target Identification
Lead sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase
Observational
Overall status
Completed
Start date
March 30, 2017
Completion date
November 30, 2024
Enrollment
1,500 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cancer cervix, cancer colorectal, cancer head neck, cancer liver, cancer of esophagus, cancer of skin, cancer of stomach, cancer of unknown origin, cancer refractory, cancer, bladder, cancer, breast, cancer, kidney, cancer, lung, cancer, uterus, hematologic neoplasms